Peptide-drug conjugates as effective prodrug strategies for targeted delivery.
about
Protease-Sensitive Nanomaterials for Cancer Therapeutics and Imaging.Drug-Bearing Supramolecular Filament Hydrogels as Anti-Inflammatory AgentsThe Good the Bad and the Ugly of Glycosaminoglycans in Tissue Engineering ApplicationsDrug delivery by supramolecular design.Multifunctional αvβ6 Integrin-Specific Peptide-Pt(IV) Conjugates for Cancer Cell Targeting.Functional oligopeptide as a novel strategy for drug delivery.Nanotherapeutic systems for local treatment of brain tumors.Exploiting cancer's phenotypic guise against itself: targeting ectopically expressed peptide G-protein coupled receptors for lung cancer therapy.A Nanosystem of Amphiphilic Oligopeptide-Drug Conjugate Actualizing Both αvβ3 Targeting and Reduction-Triggered Release for Maytansinoid.Antibody or Antibody Fragments: Implications for Molecular Imaging and Targeted Therapy of Solid TumorsPreclinical development of drug delivery systems for paclitaxel-based cancer chemotherapy.Cathepsin-Mediated Cleavage of Peptides from Peptide Amphiphiles Leads to Enhanced Intracellular Peptide Accumulation.A cascade enzymatic reaction activatable gemcitabine prodrug with an AIE-based intracellular light-up apoptotic probe for in situ self-therapeutic monitoring.Self-assembling prodrugs.Coarse-grained molecular dynamics studies of the structure and stability of peptide-based drug amphiphile filaments.Self-indicating, fully active pharmaceutical ingredients nanoparticles (FAPIN) for multimodal imaging guided trimodality cancer therapy.A Drug Screen using Human iPSC-Derived Hepatocyte-like Cells Reveals Cardiac Glycosides as a Potential Treatment for Hypercholesterolemia.Squaramide-Based Supramolecular Materials for Three-Dimensional Cell Culture of Human Induced Pluripotent Stem Cells and Their Derivatives.Gold nanoparticles stabilize peptide-drug-conjugates for sustained targeted drug delivery to cancer cells.Self-assembly behaviours of peptide-drug conjugates: influence of multiple factors on aggregate morphology and potential self-assembly mechanism.Harnessing nanostructured systems for improved treatment and prevention of HIV diseaseSelf-Assembled Nanostructures Regulate HS Release from Constitutionally Isomeric Peptides
P2860
Q30355600-2D27A2B8-6E65-4BFA-9D6F-A3A2FDE4BE88Q33836407-D5B70789-3299-4A99-B8A0-FB7AF8A57FB1Q33851544-A00E5795-051F-4D3B-8E07-CFF2BC92CFE0Q38638945-ABFB6822-36E1-4B1B-8FEF-334401F7A8C7Q38695235-0E32AC59-B9C4-4102-BF88-FF15755054F7Q38740492-2A0F4773-7523-46B6-A20E-7F256D37ADE0Q39330269-9975E371-623A-493F-917C-A90D6154AC1AQ39378866-7AC7F3BA-FCF8-471C-B74E-30B9DAAACEFAQ41239615-F7118236-69FC-4097-B295-CEDBD4D23BCFQ42655550-CA6F04AF-7324-4E1D-B916-D73B1AF56864Q47621457-B4FC8A00-F2C5-4984-A463-AA1F580C0A20Q47849287-D90394A4-9D47-4A71-896E-747D30BC1CE5Q47854170-3AAD2ED7-1A50-4B70-9656-F33EE35D8660Q47904111-71E3A6A9-36F2-44E2-B6AF-54B10CF6C5ABQ50107306-16651644-9B94-4198-8A1A-9F5BC657FE97Q50110970-22EE2DAF-6C4F-400A-8BB3-DB6CEE656DCCQ51067287-F58A3512-5BCE-4FA7-AAE8-6F064891C4B9Q52359314-F4AE00B1-166C-46C0-A546-A33165F10749Q52618433-0A7C274B-4C04-4912-A021-034350C02314Q53820054-74450E07-3F46-49A2-940D-9616B7815D5BQ56992437-31FFA206-9960-4517-B772-38E3D7321C95Q58111185-01048AB4-121E-477C-819A-C2AF4B46A3D0
P2860
Peptide-drug conjugates as effective prodrug strategies for targeted delivery.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Peptide-drug conjugates as effective prodrug strategies for targeted delivery.
@en
type
label
Peptide-drug conjugates as effective prodrug strategies for targeted delivery.
@en
prefLabel
Peptide-drug conjugates as effective prodrug strategies for targeted delivery.
@en
P2093
P2860
P1476
Peptide-drug conjugates as effective prodrug strategies for targeted delivery
@en
P2093
Andrew G Cheetham
Garren Angacian
Honggang Cui
P2860
P304
P356
10.1016/J.ADDR.2016.06.015
P407
P478
P577
2016-06-29T00:00:00Z